Comprehensive Pharmacology and Clinical Efficacy of Aromatase Inhibitors
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (2), 233-255
- https://doi.org/10.2165/00003495-199958020-00003
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- 4-hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancerEuropean Journal Of Cancer, 1992
- A phase I trial of CGS 16949a. A new aromatase inhibitorCancer, 1990
- R 76713, a new specific non-steroidal aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1988
- Alterations in the Metabolism of Oestrogens During Treatment with Aminoglutethimide in Breast Cancer PatientsClinical Pharmacokinetics, 1987
- Analogs of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituentsJournal of Medicinal Chemistry, 1987
- Aromatase inhibitors and their potential clinical significanceJournal of Steroid Biochemistry, 1986
- Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumor cytosolEuropean Journal of Cancer and Clinical Oncology, 1982
- Studies on the mechanism of estrogen biosynthesis in the rat ovary–IThe Journal of Steroid Biochemistry and Molecular Biology, 1976